PALISADE BIO, INC. (PALI) Net margin 2016–2023
PALISADE BIO, INC. (PALI) net profit margin by fiscal year — reported net income divided by reported revenue.
-4920.0%FY2023 · since FY2016: -129721.8% → -4920.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -4920.0% | — |
| FY2020 | -76346.2% | -22093.5 pp |
| FY2019 | -54252.6% | -52358.6 pp |
| FY2018 | -1894.1% | +4131.3 pp |
| FY2017 | -6025.4% | +123696.5 pp |
| FY2016 | -129721.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net incomePALI Gross profitPALI Gross marginPALI Operating incomePALI Operating marginPALI Operating cash flowPALI Free cash flowPALI Capital expendituresPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →